Metformin: Anchor in the Metabolic Journey of Prediabetes Care- Dr Dwaipayan Deb Dr Dwaipayan Deb29 April 2026 11:24 AM ISTPrediabetes affects 634.8 million adults globally, i.e., approximately 12% of the adult population (IDF, 2025), with 30.4% prevalence among Indian...
Metformin use not linked to lower Osteoarthritis Risk among diabetes patients: Study Dr. Shravani Dali20 April 2026 8:30 PM ISTResearchers have found in a new study that among individuals with newly diagnosed diabetes and no prior osteoarthritis (OA), metformin use was not...
Metformin with osteogenic and anti inflammatory properties Shows Promise in Periodontal Therapy: Study Dr. Shravani Dali19 April 2026 8:15 PM ISTMetformin demonstrates osteogenic and anti-inflammatory properties, suggesting potential as an adjunct in periodontal therapy. However, heterogeneous...
Add on Dapagliflozin to Insulin Pump Superior to add on Metformin for Glycemic Control in Diabetes: Study Dr Riya Dave13 April 2026 9:30 AM ISTResearchers have found in a new study that dapagliflozin combined with intensive insulin pump therapy provides better glycemic control than metformin...
Lupin Gets USFDA Approval for Xigduo XR Generic Dapagliflozin-Metformin Tablets Parthika Patel10 April 2026 9:14 PM ISTNew Delhi: Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and Metformin...
Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day Exclusivity Parthika Patel8 April 2026 9:22 PM ISTNew Delhi: Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Dapagliflozin and...
Metformin: Anchoring Potential in GLP-1 RA Care Journey Dr Manjunath Havalappa Dodamani8 April 2026 12:59 PM ISTIndia is confronting a metabolic health crisis of significant magnitude, 254 million adults with generalised obesity, 351 million with abdominal...
Eris Lifesciences Asked to Revise Phase IV Protocol for Dapagliflozin, Gliclazide, Metformin FDC Susmita Roy2 April 2026 6:02 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined that Eris...
Quadruple Therapy More Effective Than Metformin Dose Escalation in Diabetes, Suggests Study Medha Baranwal2 April 2026 9:30 AM ISTSouth Korea: Researchers have found in a new study from South Korea that adding a fourth oral antidiabetic drug to an existing triple therapy achieved...
NPPA Fixes Retail Prices of 31 Drug Formulations Including Atorvastatin, Empagliflozin; Details Susmita Roy28 March 2026 8:02 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of...
Expert Panel Flags Gaps in Mascot Health's Diabetes FDC Trial, Seeks Revised Phase IV Protocol Parthika Patel27 March 2026 11:12 PM ISTNew Delhi: The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) on Endocrinology and Metabolism has recommended...
